CN1094731A - 2-氨基-6，7-二羟基-4-硫杂庚酸衍生物、其制备及应用 - Google Patents

2-氨基-6，7-二羟基-4-硫杂庚酸衍生物、其制备及应用 Download PDF

Info

Publication number
CN1094731A
CN1094731A CN93121751A CN93121751A CN1094731A CN 1094731 A CN1094731 A CN 1094731A CN 93121751 A CN93121751 A CN 93121751A CN 93121751 A CN93121751 A CN 93121751A CN 1094731 A CN1094731 A CN 1094731A
Authority
CN
China
Prior art keywords
amino
compound
gly
glu
tht
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN93121751A
Other languages
English (en)
Chinese (zh)
Inventor
谷田清一
飞田恒明
胁舛光广
原田节夫
幸重浩一
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of CN1094731A publication Critical patent/CN1094731A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0819—Tripeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
CN93121751A 1992-12-28 1993-12-28 2-氨基-6，7-二羟基-4-硫杂庚酸衍生物、其制备及应用 Pending CN1094731A (zh)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP34906292 1992-12-28
JP349062/92 1992-12-28
JP5618593 1993-03-16
JP056185/93 1993-03-16
JP18173593 1993-07-22
JP181735/93 1993-07-22

Publications (1)

Publication Number Publication Date
CN1094731A true CN1094731A (zh) 1994-11-09

Family

ID=27295829

Family Applications (1)

Application Number Title Priority Date Filing Date
CN93121751A Pending CN1094731A (zh) 1992-12-28 1993-12-28 2-氨基-6，7-二羟基-4-硫杂庚酸衍生物、其制备及应用

Country Status (15)

Country Link
US (1) US5478808A (fr)
EP (1) EP0604957B1 (fr)
KR (1) KR940014436A (fr)
CN (1) CN1094731A (fr)
AT (1) ATE170871T1 (fr)
AU (1) AU666789B2 (fr)
CA (1) CA2112523A1 (fr)
DE (1) DE69320931T2 (fr)
FI (1) FI935888A (fr)
HU (1) HUT65865A (fr)
IL (1) IL108173A (fr)
NO (1) NO934834L (fr)
NZ (1) NZ250588A (fr)
PH (1) PH30687A (fr)
TW (1) TW264479B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102905703A (zh) * 2010-03-23 2013-01-30 Irm责任有限公司 作为tlr2激动剂用于治疗感染、炎症、呼吸疾病等的化合物(基于半胱氨酸的脂肽)和组合物

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030046389A (ko) * 2000-09-01 2003-06-12 그리폰 테라퓨틱스, 인코포레이티드 친핵체에 안정한 티오에스테르 발생 화합물, 제조 및 사용방법
EP1382352A1 (fr) * 2002-07-19 2004-01-21 GBF Gesellschaft für Biotechnologische Forschung mbH Conjugués de bisacylpropylcystéine et leur utilisation
DE102005024040A1 (de) * 2005-05-25 2006-12-14 Rovi Gmbh & Co. Kosmetische Rohstoffe Kg Kosmetisches oder therapeutisches Kombinationspräparat mit Theanin
AU2006259630B2 (en) * 2005-06-13 2011-10-27 Cleveland Biolabs, Inc. Methods of protecting against apoptosis using lipopeptides
WO2007099650A1 (fr) * 2006-03-01 2007-09-07 Fukuoka Prefectural Government Vecteur contenant un lipide peptidique et procede permettant d'introduire un compose dans des cellules l'utilisant
DE102009034779A1 (de) * 2009-07-25 2011-02-03 Emc Microcollections Gmbh Synthetische Analoga bakterieller Lipopeptide und ihre Anwendung zur Therapie und Prophylaxe allergischer Erkrankungen

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2860893D1 (en) * 1977-06-20 1981-11-05 Ciba Geigy Ag Lipopeptides, process for their preparation and pharmaceutical compositions containing them
EP0014815A3 (fr) * 1978-12-20 1980-10-29 Ciba-Geigy Ag Dérivés peptidiques, procédé pour leur préparation et intermédiaires, et compositions pharmaceutiques contenant un de ces composés
EP0114787B1 (fr) * 1983-01-25 1991-09-25 Ciba-Geigy Ag Dérivés peptidiques
DE3546150A1 (de) * 1985-06-24 1987-01-22 Hoechst Ag Membrananker-wirkstoffkonjugat, seine herstellung sowie seine verwendung
JPH0446194A (ja) * 1990-06-13 1992-02-17 Fujisawa Pharmaceut Co Ltd Ｗｓ１２７９ａ物質、その生産法及び用途
JPH0499796A (ja) * 1990-08-13 1992-03-31 Kazuo Achinami 新規リポペプタイド及び抗腫瘍剤
DK0548024T3 (da) * 1991-12-19 1997-01-27 Ciba Geigy Ag Aminosulfonsyrederivater samt fremgangsmåder til deres fremstilling

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102905703A (zh) * 2010-03-23 2013-01-30 Irm责任有限公司 作为tlr2激动剂用于治疗感染、炎症、呼吸疾病等的化合物(基于半胱氨酸的脂肽)和组合物
CN102905703B (zh) * 2010-03-23 2016-09-28 诺华股份有限公司 作为tlr2激动剂用于治疗感染、炎症、呼吸疾病等的化合物(基于半胱氨酸的脂肽)和组合物

Also Published As

Publication number Publication date
HU9303761D0 (en) 1994-04-28
TW264479B (fr) 1995-12-01
AU5261493A (en) 1994-07-07
DE69320931T2 (de) 1999-05-20
NO934834L (no) 1994-06-29
CA2112523A1 (fr) 1994-06-29
US5478808A (en) 1995-12-26
KR940014436A (ko) 1994-07-18
ATE170871T1 (de) 1998-09-15
NO934834D0 (no) 1993-12-27
FI935888A (fi) 1994-06-29
EP0604957A1 (fr) 1994-07-06
NZ250588A (en) 1995-03-28
DE69320931D1 (de) 1998-10-15
IL108173A (en) 1998-03-10
HUT65865A (en) 1994-07-28
IL108173A0 (en) 1994-04-12
FI935888A0 (fi) 1993-12-27
EP0604957B1 (fr) 1998-09-09
PH30687A (en) 1997-09-16
AU666789B2 (en) 1996-02-22

Similar Documents

Publication Publication Date Title
CN1225471C (zh) 具有生长激素释放特性的化合物
CN1027271C (zh) 正斯塔提尼及正环斯塔提尼多肽的制备方法
CN1198839C (zh) 作为凝血酶抑制剂的新的二肽脒类
CN1039321C (zh) 新的β－氨基－α羟基羧酸的制备方法
CN1178905C (zh) 新的肽衍生物
CN1044117C (zh) 用于抑制人免疫缺陷病毒蛋白酶的化合物及其制备方法和药物用途
CN1253441C (zh) 蛋白酶抑制剂
CN1098408A (zh) 法呢基蛋白转移酶的杂环抑制剂
CN1039596A (zh) 结合逆转录病毒蛋白酶的肽的制备方法
CN1076199A (zh) 新的肽衍生物
CN1041951A (zh) 新的肽酶抑制剂
CN1531547A (zh) 丙型肝炎三肽抑制剂
CN1119437A (zh) 环缩酚酸肽pf1022衍生物
CN1106003A (zh) 微粒体甘油三酯转移蛋白的抑制剂和方法
CN86101268A (zh) 新的肽酶抑制剂的制备方法
CN101077875A (zh) 硼酸酯和硼酸化合物,其合成和应用
CN1032786A (zh) N-酰基氨基酸衍生物及其用途
CN1553897A (zh) 多拉司他汀10衍生物
CN1272114A (zh) 苯乙胺衍生物
CN86105870A (zh) 带5-氨基-2，5-二取代-4-羟基戊酸基的血管紧张肽原酶抑制剂
CN1098409A (zh) α-哌嗪酮及其应用
CN1043647C (zh) 新的肽化合物
CN1671856A (zh) 新的生理活性物质
CN1031267C (zh) 具有抗痴功效的血管紧张素转化酶抑制剂的制备方法
CN1098404A (zh) 用作治疗爱滋病的人免疫缺陷病毒蛋白酶抑制剂

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication